Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with ... and Switzerland under the Awiqli brand name, as well as in China. Eli Lilly is its nearest rival, developing ...
GlobalData on MSN12mon
EMA CHMP recommends Novo Nordisk’s weekly insulin for diabetesThe overall profile of once-weekly basal insulin icodec was found to be safe ... a GlobalData owned brand. The information on ...
compared the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in hospitalized general medical patients with type 2 diabetes. The prospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results